OU scientists developing new anti-cancer drug
OU scientists developing new anti-cancer drug
Comments
4
By Jim Killackey
Published: September 5, 2008
A drug designed to keep pancreatic cancer and other tumorous tissues from recurring is being developed by scientists at the University of Oklahoma Health Sciences Center.
The medicine, probably in a pill or injectable form, would be given after patients are treated successfully using chemotherapy and radiation, said cancer researcher Dr. Courtney Houchen. More than 400 Oklahomans are killed each year by pancreatic cancer, which is the fourth-leading cause of cancer fatalities in the United States, according to the National Cancer Institute. Houchen said today at an Oklahoma City news conference that the drug has been effective in animal testing and cell cultures. Researchers expect human clinical trials will begin about five years from now. The drug might then be available to the public in 10 years, he said. A perfect candidate for the drug would be Duncan pancreatic survivor Jim Edwards, 53. He said the drug could be “a new insurance policy ... in the future for me and my family.”
Related Topics:
Science and Technology, Technology, Health and Fitness, Medicine, Special Interest Groups, Sciences, Medical Treatments and Procedures, Cancer, Animal Rights, Animal Cruelty, Medical Technology, Medical Drug Therapy, Pancreatic Cancer, Clinical Trials

Prev

Something to say about this topic? Submit a Letter to the Editor online
Thank you for joining our conversations on newsok. We encourage your discussions but ask that you stay within the bounds of our terms and conditions. Please help us by reporting comments that violate these guidelines. To review our rules of engagement, go to Commenting and posting policy.
Log in below or sign up (it's free).